Blog - The Crucial Role of Early Detection in DVT and PE :: Transasia Bio-Medicals

Scientific Updates

Blog - The Crucial Role of Early Detection in DVT and PE

Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) are two interrelated medical conditions that can have severe consequences if left undiagnosed and untreated. The incidence of DVT in India in the general population is 1.79 per thousand. Nearly 30% of patients with symptomatic VTE manifest with PE and others with DVT. DVT involves the formation of clots in deep veins, usually in the legs, while PE occurs when these clots break free and travel to the lungs, potentially blocking crucial blood flow. Early diagnosis is crucial to prevent life-threatening complications associated with these thrombotic disorders. 

Why is early diagnosis essential?

Early diagnosis of DVT and PE can significantly improve patient outcomes and reduce the risk of the following serious consequences:

                     

Diagnosing thrombotic disorders

Several diagnostic methods enable prompt diagnosis of DVT and PE. A combination of one or more of these diagnostic methods can help confirm the diagnosis.

Clinical Assessment: A thorough medical history and physical examination can provide valuable clues. Common signs and symptoms of DVT include leg pain, swelling, redness, and warmth. PE may present with symptoms such as chest pain, shortness of breath, rapid heart rate, and coughing up blood.

D-dimer Blood Test: This blood test measures the presence of D-dimer, a substance released when a blood clot breaks up. Elevated D-dimer levels may suggest the presence of an active clot but are not specific to DVT or PE. It often serves as a screening tool to determine the need for further testing.

Other techniques include:

   

Transasia’s clinical diagnostic solutions for the timely detection of blood clots

The Transasia-Erba Group offers a comprehensive range of products designed for the early detection of coagulation disorders. This includes advanced tools for measuring D-dimer levels and a state-of-the-art semi- and fully-automated ECL series of single channel, 4-channel and 7-channel coagulation analyzers, including ECL 105, ECL 412, and ECL 760 respectively. These cutting-edge solutions play a crucial role in identifying clotting disorders at an early stage.

Early diagnosis of Deep Vein Thrombosis and Pulmonary Embolism is vital for preventing serious consequences, including potentially life-threatening complications. Healthcare providers use a combination of clinical assessment and various diagnostic methods, such as ultrasound, CT scans, and blood tests, to accurately diagnose these thrombotic disorders. 

Ref: 

https://www.nams-india.in/downloads/Taskforce/01%20NAMS%20%20Task%20Force%20report%20%20on%20Venus%20Thrombo.pdf